A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 63, Issue 6, 2011, Pages 1497-1506

  Davis III, John M ^a   Knutson, Keith L ^a   Strausbauch, Michael A ^a   Crowson, Cynthia S ^a   Therneau, Terry M ^a   Wettstein, Peter J ^a   Roger, Veronique L ^a   Matteson, Eric L ^a   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOCORTICOID; INTERLEUKIN 6;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DETERIORATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EX VIVO STUDY; FEMALE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; INNATE IMMUNITY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; STIMULUS RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79958023277     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30323     Document Type: Article

References (48)

1. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 412-20. (Pubitemid 40216304)
2. Wolfe F, Michaud K,. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004; 116: 305-11. (Pubitemid 38230289)
3. Davis JM III, Roger VL, Crowson CS, Maradit Kremers H, Therneau TM, Gabriel SE,. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008; 58: 2603-11.
4. Nicola PJ, Maradit Kremers H, Crowson CS, Ballman KV, Gabriel SE,. Do rheumatoid arthritis (RA) disease characteristics predict congestive heart failure? [abstract]. Arthritis Rheum 2004; 50 Suppl: S551.
5. Giles JT, Fernandes V, Lima JA, Bathon JM,. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005; 7: 195-207. (Pubitemid 41335156)
6. Grundtman C, Hollan I, Forre OT, Saatvedt K, Mikkelsen K, Lundberg IE,. Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis Rheum 2010; 62: 667-73.
7. Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y,. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol 2007; 34: 2005-9. (Pubitemid 47548202)
8. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2004; 33: 231-8. (Pubitemid 38280822)
9. Levendoglu F, Temizhan A, Ugurlu H, Ozdemir A, Yazici M,. Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study. Rheumatol Int 2004; 24: 141-6. (Pubitemid 38797626)
10. Alpaslan M, Onrat E, Evcik D,. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol 2003; 22: 84-8. (Pubitemid 36748853)
11. Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L, et al. Diastolic function abnormalities in rheumatoid arthritis: evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis 2000; 59: 227-9. (Pubitemid 30305594)
12. Montecucco C, Gobbi G, Perlini S, Rossi S, Grandi AM, Caporali R, et al. Impaired diastolic function in active rheumatoid arthritis: relationship with disease duration. Clin Exp Rheumatol 1999; 17: 407-12. (Pubitemid 29343623)
13. Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G,. Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 1996; 26: 293-7. (Pubitemid 26147064)
14. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1665-70.
15. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ,. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202. (Pubitemid 36068707)
16. Davis JM III, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, et al. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol 2010; 184: 7297-304.
17. Maradit Kremers H, Crowson CS, Gabriel SE,. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004; 30: 819-34, vii. (Pubitemid 39361475)
18. Efron B,. The jackknife, the bootstrap and other resampling plans. CBMS-NSF Regional Conference Series in Applied Mathematics. Vol. 38. Philadelphia: Society for Industrial & Applied Mathematics; 1982.
19. Efron B, Tibshirani R,. An introduction to the bootstrap. Boca Raton (FL): Chapman & Hall/CRC; 1998.
20. Achong N, Wahi S, Marwick TH,. Evolution and outcome of diastolic dysfunction. Heart 2009; 95: 813-8.
21. Zhang Y, Safar ME, Iaria P, Agnoletti D, Protogerou AD, Blacher J,. Prevalence and prognosis of left ventricular diastolic dysfunction in the elderly: The PROTEGER Study. Am Heart J 2010; 160: 471-8.
22. Berner B, Akca D, Jung T, Muller GA, Reuss-Borst MA,. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000; 27: 1128-35. (Pubitemid 30262494)
23. Allen ME, Young SP, Michell RH, Bacon PA,. Altered T lymphocyte signaling in rheumatoid arthritis. Eur J Immunol 1995; 25: 1547-54.
24. Kusaba M, Honda J, Fukuda T, Oizumi K,. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol 1998; 25: 1466-71. (Pubitemid 28364747)
25. Huang Q, Ma Y, Adebayo A, Pope RM,. Increased macrophage activation mediated through Toll-like receptors in rheumatoid arthritis. Arthritis Rheum 2007; 56: 2192-201. (Pubitemid 47173566)
26. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004; 50: 1457-67. (Pubitemid 38608067)
27. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, van den Hoogen FH, et al. The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005; 52: 2313-22. (Pubitemid 41117415)
28. Kowalski ML, Wolska A, Grzegorczyk J, Hilt J, Jarzebska M, Drobniewski M, et al. Increased responsiveness to Toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis. Mediators Inflamm 2008; 2008: 132732.
29. Leirisalo-Repo M, Paimela L, Jaattela M, Koskimies S, Repo H,. Production of TNF by monocytes of patients with early rheumatoid arthritis is increased. Scand J Rheumatol 1995; 24: 366-71. (Pubitemid 26041937)
30. Fabris M, Tolusso B, Di Poi E, Tomietto P, Sacco S, Gremese E, et al. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression. J Rheumatol 2005; 32: 998-1005. (Pubitemid 40828069)
31. Kawashima M, Miossec P,. mRNA quantification of T-bet, GATA-3, IFN-γ, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity. J Clin Immunol 2005; 25: 209-14. (Pubitemid 40884046)
32. Macht LM, Elson CJ, Kirwan JR, Gaston JS, Lamont AG, Thompson JM, et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology 2000; 99: 208-14. (Pubitemid 30093665)
33. Van Roon JA, Verhoef CM, van Roy JL, Gmelig-Meyling FH, Huber-Bruning O, Lafeber FP, et al. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis 1997; 56: 656-60. (Pubitemid 28007922)
34. Berg L, Lampa J, Rogberg S, van Vollenhoven R, Klareskog L,. Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors. Ann Rheum Dis 2001; 60: 133-9. (Pubitemid 32102204)
35. Kawashima M, Miossec P,. Effect of treatment of rheumatoid arthritis with infliximab on IFNγ, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity. Ann Rheum Dis 2005; 64: 415-8. (Pubitemid 40283052)
36. Seitz M, Zwicker M, Wider B,. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment. J Rheumatol 2001; 28: 496-501. (Pubitemid 32202649)
37. Haugen E, Gan LM, Isic A, Skommevik T, Fu M,. Increased interleukin-6 but not tumour necrosis factor-α predicts mortality in the population of elderly heart failure patients. Exp Clin Cardiol 2008; 13: 19-24. (Pubitemid 351425258)
38. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008; 51: 1775-83. (Pubitemid 351608497)
39. Karpinski L, Plaksej R, Kosmala W, Witkowska M,. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol 2008; 66: 1279-85.
40. Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, et al. Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 2009; 24: 22-6.
41. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr., Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004; 109: 3176-81.
42. Harney SM, Timperley J, Daly C, Harin A, James T, Brown MA, et al. Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 136. (Pubitemid 41815659)
43. Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, et al. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2662-9.
44. Provan SA, Angel K, Odegard S, Mowinckel P, Atar D, Kvien TK,. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study. Arthritis Res Ther 2008; 10: R70.
45. Crowson CS, Myasoedova E, Davis JM III, Roger VL, Karon BL, Borgeson D, et al. B-type natriuretic peptide is a poor screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 2011. E-pub ahead of print.
46. Davis JM III, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007; 56: 820-30. (Pubitemid 46399429)
47. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004; 90: 859-65. (Pubitemid 39005927)
48. Wei L, MacDonald TM, Walker BR,. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-70.